Compare ANIP & SHCO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ANIP | SHCO |
|---|---|---|
| Founded | 2001 | 1995 |
| Country | United States | United Kingdom |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Hotels/Resorts |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.0B | 1.7B |
| IPO Year | N/A | 2021 |
| Metric | ANIP | SHCO |
|---|---|---|
| Price | $80.69 | $9.00 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 6 | 1 |
| Target Price | ★ $107.33 | $9.00 |
| AVG Volume (30 Days) | 532.5K | ★ 2.3M |
| Earning Date | 02-27-2026 | 11-07-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ 1.67 | N/A |
| Revenue | $826,880,000.00 | ★ $1,288,973,000.00 |
| Revenue This Year | $44.35 | $11.89 |
| Revenue Next Year | $11.13 | $7.87 |
| P/E Ratio | $48.56 | ★ N/A |
| Revenue Growth | ★ 48.87 | 8.48 |
| 52 Week Low | $54.10 | $4.77 |
| 52 Week High | $99.50 | $8.98 |
| Indicator | ANIP | SHCO |
|---|---|---|
| Relative Strength Index (RSI) | 43.45 | 59.60 |
| Support Level | $83.03 | $8.86 |
| Resistance Level | $86.97 | $8.92 |
| Average True Range (ATR) | 3.55 | 0.18 |
| MACD | -0.04 | 0.07 |
| Stochastic Oscillator | 40.94 | 99.76 |
ANI Pharmaceuticals Inc develops, manufactures, and markets generic prescription pharmaceuticals. It manufactures liquid, powder, and oral solid-dose products. Its areas of product development include narcotics, oncolytics, hormones and steroids, and complex formulations involving extended-release and combination products. Some of its generic products include Erythromycin ethyl succinate, Esterified Estrogen with Methyltestosterone (EEMT), Etodolac Fenofibrate, Fluvoxamine, Hydrocortisone Enema and Vancomycin. The company operates in two segments which include Rare Diseases and Brands, Generics, and Others. Its geographical segments are the United States and Canada, of which the majority of its revenue comes from the United States.
Soho House & Co Inc is a membership platform of physical and digital spaces that connects a vibrant, diverse group of members from across the world. The members use the platform to work, socialize, connect, create, and flourish all over the world. It offers lease agreements for Houses, hotels, restaurants, studios, spas, and other properties. The company's reportable segments are: United Kingdom; The Americas; and Europe and Rest of the world. The majority of its revenue is generated from the Americas segment, which encompasses its operating units in the Americas, including Soho Houses, stand-alone U.S. restaurants, Soho Friends, and the management fees under a hotel management contract for the operation of The Ned London.